Sefunda is a in-vitro diagnostics startup focussing on AMR and cost-effectivenes. Increasing antimicrobial drug resistance has become a global health threat. According to the CDC around 50% of the 1.6 million new gonorrhea infections/year in the U.S. are resistant to at least one antibiotic.

Facts & figures
  • Type of organization
    Public company
  • Year of foundation
  • Number of employees in Switzerland
Key business

You may also be interested in